Surgical rationalization of living donor liver transplantation by abolition of hepatic artery reconstruction under a fixed microscope
Takahito Yagi(Okayama University), Toshiyoshi Fujiwara(Okayama University), Masashi Utsumi(Okayama University), Daisuke Sato(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Susumu Shinoura(Okayama University), Kazuhiro Yoshida(Nagasaki University), Yuzo Umeda(Okayama University), Hiroshi Sadamori(Okayama University), Ryuichi Yoshida(Okayama University)
Cited by 18
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178